Lung Diseases Clinical Trial
To assess associations between behavioral/neuropsychological measures and various measures of sleep disordered breathing (SDB) and to determine the prevalence of SDB in children with Attention Deficit Hyperactivity Disorder (ADHD).
BACKGROUND:
Obstructive sleep apnea syndrome (OSAS) is a relatively frequent condition which may affect
up to 2-3 percent of school age children. The morbidity of untreated OSAS may include
failure to thrive, pulmonary and systemic hypertension, and behavioral and neurocognitive
deficiencies. However, it remains unclear to what extent OSAS impinges on aspects of
neurocognitive and behavioral function, and whether sleep fragmentation, intermittent
hypoxemia, and alveolar hypoventilation, which are the three major physiological alterations
in OSAS, selectively affect particularly vulnerable components of neurocognitive function.
Furthermore, certain similarities exist between the behavioral alterations occurring in OSAS
and those seen in children with the Attention Deficit Hyperactivity Disorder (ADHD).
The study is in response to a Request for Applications (RFA) on Obstructive Sleep Apnea in
Children. NHLBI issued the RFA in December, 1997, with co-sponsorship from the National
Institute of Dental and Craniofacial Research and the National Institute of Child Health and
Human Development.
DESIGN NARRATIVE:
The cross-sectional study tested the hypothesis that OSAS is detrimental to particular
aspects of neurocognitive and behavioral functioning. Snoring 6 year-old children attending
the public elementary school system in New Orleans Parish were prospectively identified by
an appropriate questionnaire and enrolled in the study. Snoring children underwent overnight
polysomnographic assessment to determine the presence and severity of OSAS, and their
neurocognitive and behavioral functions were subsequently evaluated employing the Wechsler
Intelligence Scale for Children-III, the Conners' Continuous Performance Test, and the
Cambridge Neuropsychological Test Automated Battery test. Multivariate regression and
analyses of variance allowed for determination of aspects of neurocognitive function and
behavior that were vulnerable to OSAS in general, and to each of OSAS components in
particular.
The study also tested the hypothesis that children with ADHD may have increased prevalence
of snoring and OSAS. Children with this diagnosis were initially confirmed as having ADHD
using the revised Diagnostic Interview for Children and Adolescents, the Conners' Parent
Rating Scale, and the Child Behavior Checklist. ADHD children then underwent
polysomnographic evaluation as well as extensive evaluation of neurocognitive function and
behavior as above. The prevalence of snoring and OSAS were then calculated.
The study was extended through June 2007 to test the hypothesis that SDB will induce
systemic inflammatory responses, and that the magnitude of such inflammatory response will
be the major determinant of the severity of neurocognitive dysfunction associated with SDB.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Completed |
NCT04908397 -
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
|
Phase 1 | |
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Completed |
NCT03682354 -
ESPB Versus INB With PCIA in Video-assisted Thoracic Surgery
|
N/A | |
Enrolling by invitation |
NCT03683186 -
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
|
Phase 3 | |
Completed |
NCT03626519 -
Effects of Menthol on Dyspnoea in COPD Patients
|
N/A | |
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Completed |
NCT02926768 -
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
Completed |
NCT00269256 -
Stress, Environment, and Genetics in Urban Children With Asthma
|
N/A | |
Terminated |
NCT00233207 -
IC14 Antibodies to Treat Individuals With Acute Lung Injury
|
Phase 2 | |
Completed |
NCT00281216 -
Innate and Adaptive Immunity in Individuals Experiencing Chronic Obstructive Pulmonary Disease Exacerbations
|
N/A | |
Recruiting |
NCT00129350 -
Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
|
Phase 1 | |
Active, not recruiting |
NCT00115297 -
Montelukast for Early Life Wheezing
|
Phase 2/Phase 3 | |
Completed |
NCT00091767 -
Genetic Studies in Difficult to Treat Asthma: TENOR
|
N/A | |
Completed |
NCT00094276 -
Intervention for Improving Asthma Care for Minority Children in Head Start
|
N/A | |
Completed |
NCT00069823 -
Study of Acid Reflux in Asthma
|
Phase 3 | |
Completed |
NCT00083798 -
Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
|
N/A | |
Completed |
NCT00089752 -
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
|
N/A |